Attovia’s Upsized IPO Brings In $289M to Fund New Kind of Biologic for Immune Disorders
Attovia Therapeutics’ biologic medicines might supply benefits over at the moment obtainable immune dysfunction medicine, equivalent to Sanofi’s blockbuster drugs ...